Last reviewed 2026-05-27 · How we verify

tetrachloroethylene

unknown active ✓ Verified May 2026

tetrachloroethylene is a drug. It is currently in unknown development.

Tetrachloroethylene is a volatile, non-flammable, stable, colorless and dense liquid used for dry cleaning of fabrics and as a metal degreasing solvent. It is a small molecule with the formula Cl2C=CCl2, classified as a chlorocarbon.

At a glance

Generic name	tetrachloroethylene
Therapeutic area	Other
Phase	unknown

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Addressing Tetrachloroethylene Exposure in an Impacted Community: Residents' Concerns, Neurotoxic Effects, and Exposure Reduction (NA)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

tetrachloroethylene CI brief — competitive landscape report
tetrachloroethylene updates RSS · CI watch RSS
portfolio CI

Frequently asked questions about tetrachloroethylene

What is tetrachloroethylene?

tetrachloroethylene is a pharmaceutical drug.

What development phase is tetrachloroethylene in?

tetrachloroethylene is in unknown.

Manufacturer: — full pipeline
Therapeutic area: All drugs in Other

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing